Due to the rarity of the disease, there is only limited information on the optimal treatment for patients. Treatment is therefore based on the patient's symptoms. If there is an underlying monoclonal gammopathy, it is treated according to relevant guidelines.
Crystal-storing histiocytosis
Sea-blue histiocytosis
X-type histiocytosis
Langerhans cell histiocytosis
Non-Langerhans cell histiocytosis
Non-X histiocytosis
Malignant histiocytosis
Progressive nodular histiocytosis